8
Oct
2024

Chengdu Shuode Pharmaceutical Co., Ltd

Exhibitor at CPHI Milan 2024 stand 16F73, Finished Dosage Formulations
About Us

Chengdu Shuode Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Chengdu Easton Biopharmaceuticals Co., Ltd. (Stock code: 688513), with a registered capital of 850 million yuan, located in Chengdu Tianfu International Bio-town, Shuangliu District, Chengdu. Main business: Finished dosage form production and international sales in an integrated pharmaceutical enterprise, while providing international FDF CDMO services. At present, the company mainly has four international producation workshops for injection, oral solution, solid dosage, nassal spray and PFS.

  • CN
  • 2023
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Contact info
  • No. 9 Lekang Road, Shuangliu District, 610200, Chengdu, Sichuan, China
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16F73, Finished Dosage Formulations